These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 32416

  • 1. Antiarrhythmic effect of oxprenolol on halothane-epinephrine and coronary ligation induced ventricular arrhythmias in beagle dogs.
    Hashimoto K, Tsukada T, Matsuda H, Matsubara I, Imai S.
    Jpn J Pharmacol; 1978 Aug; 28(4):535-44. PubMed ID: 32416
    [Abstract] [Full Text] [Related]

  • 2. [Experimental anti-arrhythmic effects of a new beta-adrenergic receptor blocking agent, dl-l-(tert. butylamino)-3-[(2-propinyloxy)phenoxy]2-propanol hydrochloride (dl Kö 1400-Cl)].
    Matsubara I, Hashimoto K, Katano Y, Tsukada T, Matsuda H.
    Nihon Yakurigaku Zasshi; 1976 Jul; 72(5):557-71. PubMed ID: 11153
    [Abstract] [Full Text] [Related]

  • 3. Antiarrhythmic effects of bupuranolol against canine ventricular arrhythmias induced by halothane-adrenaline or two-stage coronary ligation.
    Hashimoto K, Tsukada T, Matsuda H, Nakagawa Y, Imai S.
    J Cardiovasc Pharmacol; 1979 Jul; 1(2):205-17. PubMed ID: 94390
    [Abstract] [Full Text] [Related]

  • 4. Canine digitalis arrhythmia as a model for detecting Na-channel blocking antiarrhythmic drugs: a comparative study using other canine arrhythmia models and the new antiarrhythmic drugs, propafenone, tocainide, and SUN 1165.
    Hashimoto K, Ishii M, Komori S, Mitsuhashi H.
    Heart Vessels; 1985 Feb; 1(1):29-35. PubMed ID: 2419304
    [Abstract] [Full Text] [Related]

  • 5. Esmolol prevents and suppresses arrhythmias during halothane anaesthesia in dogs.
    Dimich I, Lingham R, Narang J, Sampson I, Shiang H.
    Can J Anaesth; 1992 Jan; 39(1):83-6. PubMed ID: 1346371
    [Abstract] [Full Text] [Related]

  • 6. Antiarrhythmic effects of flecainide against canine ventricular arrhythmias induced by two-stage coronary ligation and halothane-epinephrine.
    Dobmeyer D, Muir WW, Schaal SF.
    J Cardiovasc Pharmacol; 1985 Jan; 7(2):238-44. PubMed ID: 2581074
    [Abstract] [Full Text] [Related]

  • 7. Antiarrhythmic effects of a novel class III drug, KCB-328, on canine ventricular arrhythmia models.
    Xue Y, Tanabe S, Nabuchi Y, Hashimoto K.
    J Cardiovasc Pharmacol; 1998 Aug; 32(2):239-47. PubMed ID: 9700986
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Anti-arrhythmic effect of nadolol in experimental arrhythmias: comparison with propranolol and alprenolol.
    Nakashima M, Takiguchi Y, Oguro K, Sogabe K, Hashimoto H.
    J Pharmacobiodyn; 1985 Jan; 8(1):1-10. PubMed ID: 4009395
    [Abstract] [Full Text] [Related]

  • 11. Antiarrhythmic properties of 5-(3-tert-butylamino-2-hydroxy)propoxy-3,4-dihydrocarbostyril hydrochloride (OPC-1085), a newly synthesized, potent beta-adrenoreceptor antagonist.
    Yabuuchi Y, Hashimoto K, Yamashita S, Uno T, Shintani S, Nakagiri N.
    Clin Exp Pharmacol Physiol; 1977 Jan; 4(6):545-59. PubMed ID: 22416
    [Abstract] [Full Text] [Related]

  • 12. The effect of beta-adrenoceptor blocking agents, with differing ancillary properties, on the arrhythmias resulting from acute coronary artery ligation in anaesthetized rats.
    Campbell CA, Parratt JR.
    Br J Pharmacol; 1983 Aug; 79(4):939-46. PubMed ID: 6140049
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Abnormal ECG and adrenaline-induced arrhythmias in restraint and water immersion stressed mice and effects of oxprenolol].
    Kita T, Hata T, Harada N, Itoh E.
    Nihon Yakurigaku Zasshi; 1984 May; 83(5):373-82. PubMed ID: 6147301
    [Abstract] [Full Text] [Related]

  • 15. Antiarrhythmic effects of coronary vasodilators on canine ventricular arrhythmia models.
    Komori S, Ishii M, Hashimoto K.
    Jpn J Pharmacol; 1985 May; 38(1):73-82. PubMed ID: 4021230
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effective plasma concentrations of antiarrhythmic drugs against sustained halothane-adrenaline arrhythmia in dogs.
    Shibuya T, Hashimoto K, Imai S.
    J Cardiovasc Pharmacol; 1983 May; 5(4):538-45. PubMed ID: 6193348
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.